Effects on Pain and Mobility of a New Diet Supplement in Dogs with Osteoarthritis: A Pilot Study
Authors/Creators
- 1. Scientific Consultant, Beeston, UK
- 2. Ambulatorio Vernazza, Torino, Italy
- 3. RTI International, Washington, DC, USA; Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK
- 4. Department of Veterinary Sciences, University of Turin, Grugliasco (TO), Italy
- 5. Department of Drug Science and Technology, University of Turin, Torino, Italy
- 6. Clinica Veterinaria Monferrato, Alessandria, Italy
- 7. Ambulatorio Veterinario Noè, Arquata Scrivia (AL), Italy
- 8. Candioli Pharma S.r.l, Beinasco (TO), Italy
Description
In this study, we have evaluated the efficacy of a new diet supplement in reducing chronic pain and improving mobility in a group of 10 dogs with Osteoarthritis (OA). OA is a common debilitating condition affecting humans and animals. Tablets containing a preparation of natural ingredients (Cannabidiol (CBD)-rich fraction, Boswellia serrata Roxb. in a Phytosome® delivery form and Cucumis melo L. extract) were administered for 30 days. Veterinary evaluations were performed and owners filled questionnaires on chronic pain (Helsinki chronic pain index- HCPI) three times during the study. The product was well tolerated and owners reported a good palatability and ease of administration. In terms of effectiveness, results of a Generalized Linear Mixed Model (GLMM) on HCPI highlighted a significant reduction of pain scores at the end of the study. Based on our observations, our new dietary supplement has beneficial effects in dogs with OA after the treatment.